IC
WVE icon

Ikarian Capital’s Wave Life Sciences WVE Stock Holding History

Ikarian Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$618K Hold
85,285
– – 0.05% 123
2025
Q4 		$1.45M Sell
85,285
-10,670
-11% -$108K 0.11% 120
2025
Q3 		$702K Sell
95,955
-65,182
-40% -$527K 0.07% 132
2025
Q2 		$1.05M Buy
+161,137
New +$1.06M 0.2% 82
2024
Q4 		– Sell
-544,265
Closed -$4.46M – 208
2024
Q3 		$4.46M Sell
544,265
-30,823
-5% -$184K 0.62% 49
2024
Q2 		$2.87M Sell
575,088
-15,000
-3% -$85.6K 0.5% 48
2024
Q1 		$3.64M Buy
+590,088
New +$2.95M 0.4% 63
2022
Q3 		– Sell
-98,039
Closed -$318K – 162
2022
Q2 		$318K Sell
98,039
-950,000
-91% -$1.83M 0.06% 109
2022
Q1 		$2.1M Buy
1,048,039
+54,558
+5% +$134K 0.28% 65
2021
Q4 		$3.12M Hold
993,481
– – 0.46% 49
2021
Q3 		$4.87M Buy
+993,481
New +$6.02M 0.34% 68

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return